PT Lavender Bina Cendikia Tbk (IDX:BMBL)
Indonesia · Delayed Price · Currency is IDR 36.00
+1.00 (2.78%)
Aug 8, 2025, 3:49 PM WIB
Verve Therapeutics Revenue
PT Lavender Bina Cendikia Tbk had revenue of 4.02B IDR in the quarter ending June 30, 2025, with 1.44% growth. This brings the company's revenue in the last twelve months to 11.58B, down -30.73% year-over-year. In the year 2024, PT Lavender Bina Cendikia Tbk had annual revenue of 11.47B, down -33.58%.
Revenue (ttm)
11.58B
Revenue Growth
-30.73%
P/S Ratio
3.20
Revenue / Employee
1.65B
Employees
7
Market Cap
37.08B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11.47B | -5.80B | -33.58% |
| Dec 31, 2023 | 17.27B | 4.74B | 37.86% |
| Dec 31, 2022 | 12.53B | 4.66B | 59.22% |
| Dec 31, 2021 | 7.87B | 1.93B | 32.44% |
| Dec 31, 2020 | 5.94B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Indofood CBP Sukses Makmur Tbk | 73.24T |
| PT Sumber Alfaria Trijaya Tbk | 122.82T |
| PT Charoen Pokphand Indonesia Tbk | 67.58T |
| PT Indofood Sukses Makmur Tbk | 118.33T |
| PT Unilever Indonesia Tbk | 34.30T |
| PT Hanjaya Mandala Sampoerna Tbk | 52.15T |
| PT Mayora Indah Tbk | 37.65T |
| PT Cisarua Mountain Dairy Tbk | 9,758.44B |